MLTX- Moonlake Immunotherapeutics

Over the past 90 days, insiders at Moonlake Immunotherapeutics (MLTX) have been net sellers, shedding 1,100 shares worth roughly $22K on balance.

Classified under Biotechnology (Health Care sector), MLTX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Santos Da Silva Jorge	2.77M	$55.55M	-
Other	Reich Kristian	2.71M	$54.22M	-
CFO	Bodenstedt Matthias	1.12M	$24.58M	-
Dir	Loy Spike	22.2K	-	-
10%	Bvf Partners L P/il	22.2K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 27, 2026	Reich Kristian78	Chief Scientific Officer	Sell	1,100	$20.00	$22,000.00	-	-	-
Jul 22, 2026	Reich Kristian78	Chief Scientific Officer	Sell	52,448	$20.02	$1,049,960.00	-1.9%	-	-
Jul 20, 2026	Reich Kristian78	Chief Scientific Officer	Sell	43,700	$20.09	$877,933.00	-1.6%	-	-
Jul 15, 2026	Reich Kristian78	Chief Scientific Officer	Sell	16,105	$20.01	$322,261.05	-0.6%	-	-
Jul 10, 2026	Santos Da Silva Jorge77	Chief Executive Officer	Sell	102,225	$20.02	$2,046,205.14	-3.6%	-	-
Jul 1, 2026	Santos Da Silva Jorge77	Chief Executive Officer	Sell	47,775	$20.03	$956,933.25	-1.6%	-	-
Jun 22, 2026	Bodenstedt Matthias66	Chief Financial Officer	Sell	39,120	$22.04	$862,204.80	-3.4%	-	-
Jun 18, 2026	Bodenstedt Matthias66	Chief Financial Officer	Sell	17,876	$19.67	$351,576.16	-1.5%	-	-
Jun 17, 2026	Reich Kristian78	Chief Scientific Officer	Sell	150,000	$19.01	$2,851,000.00	-5.0%	-	-
May 11, 2026	Bodenstedt Matthias66	Chief Financial Officer	Sell	13,653	$20.02	$273,333.06	-1.2%	-	-